FDA Drug Application (022311) for MOZOBIL by GENZYME

Back to FDA Applications sponsored by GENZYME

Application Number022311
Product Number001
FormSOLUTION;SUBCUTANEOUS
Dosage24MG/1.2ML (20MG/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameMOZOBIL
Active IngredientPLERIXAFOR



Back to FDA Applications sponsored by GENZYME

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.